Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) just unveiled an update.
Shanghai Pharmaceuticals Holding Co., Ltd. has announced a change in the composition of its board committee. Ms. MAN Kwan has been appointed as a member of the Nomination Committee, effective from March 27, 2025. This appointment is part of the company’s ongoing efforts to strengthen its governance and enhance its strategic direction.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a major player in the pharmaceutical industry in China, focusing on the development, manufacturing, and distribution of pharmaceutical products and healthcare services.
YTD Price Performance: -8.59%
Average Trading Volume: 33,967
Technical Sentiment Signal: Sell
Current Market Cap: $7.67B
See more insights into 2607 stock on TipRanks’ Stock Analysis page.